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Abstract
A variety of pluripotency reprogramming frequencies from different somatic cells has been
observed, indicating cell origin is a critical contributor for efficiency of pluripotency repro-
gramming. Identifying the cell sources for efficient induced pluripotent stem cells (iPSCs)
generation, and defining its advantages or disadvantages on reprogramming, is therefore
important. Human ocular tissue-derived conjunctival epithelial cells (OECs) exhibited
endogenous expression of reprogramming factors OCT4A (the specific OCT 4 isoform on
pluripotency reprogramming) and SOX2. We therefore determined whether OECs could be
used for high efficiency of iPSCs generation. We compared the endogenous expression lev-
els of four pluripotency factors and the pluripotency reprograming efficiency of human
OECs with that of ocular stromal cells (OSCs). Real-time PCR, microarray analysis, West-
ern blotting and immunostaining assays were employed to compare OECiPSCs with
OSCiPSCs on molecular bases of reprogramming efficiency and preferred lineage-differen-
tiation potential. Using the traditional KMOS (KLF4, C-MYC,OCT4 and SOX2) reprogram-
ming protocol, we confirmed that OECs, endogenously expressing reprogramming factors
OCT4A and SOX2, yield very high efficiency of iPSCs generation (~1.5%). Furthermore,
higher efficiency of retinal pigmented epithelial differentiation (RPE cells) was observed in
OECiPSCs compared to OSCiPSCs or skin fibroblast iMR90iPSCs. The findings in this
study suggest that conjunctival-derived epithelial (OECs) cells can be easier converted to
iPSCs than conjunctival-derived stromal cells (OSCs). This cell type may also have advan-
tages in retinal pigmented epithelial differentiation.
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Introduction
Introduction of exogenous reprogramming factors KLF4, C-MYC, OCT4 and SOX2 (KMOS)
reprograms somatic cells to induced pluripotent stem cells (iPSCs) [1, 2]. Recent developments
in reprogramming techniques using episome or mRNA-based assay have resulted in the suc-
cessful generation of iPSCs without integration of exogenous components or genes in genome.
These techniques in turn facilitate the applications of iPSCs in personalized regenerative and
pharmaceutical medicine[3]. Nonetheless there remain many challenges remain prior to their
widespread clinical applications. For example, although iPSCs now can be generated without a
genome integrating approach, i.e. miRNA, episome, sendai-viral, mRNA and small molecules,
the efficiency of iPSCs production remains relative low (~0.1%)[4, 5]. In addition, the efficiency
of differentiation of iPSCs to the desired cell lineage varies among different iPSCs lines. It
remains unclear which particular somatic cell sources are preferable for reprogramming.
Among the four reprogramming factors, KLF4 and c-MYC could be replaced by other fac-
tors. In contrast, OCT4 and SOX2 are thought to be essential for induction and maintenance
of pluripotent identity. Although it has recently been discovered that mesendodermal and ecto-
dermal lineage specifiers can induce pluripotency in the absence of both OCT4 and SOX2 [6,
7], the mechanisms by which lineage specifiers affect reprogramming remain elusive. There is
no consensus on the selection of the cell sources for reprogramming to iPSCs [1, 8–14] or on
which particular donor cell type has a higher efficiency of specific cell-type differentiation from
its corresponding iPSCs [15]. Thus, the varying efficiencies in reprogramming of different
somatic cell sources suggests that cell origin be an influence. Recent studies have further dem-
onstrated that iPSCs may differentiate towards their cell-of-origin. The identification of appro-
priate adult somatic cell types with favorable properties for pluripotency reprogramming and
preferred lineage differentiation, and definition of their advantages and disadvantages are
therefore of high clinical value. Here, we reported that human adult conjunctiva epithelial cells
(OECs) with endogenous expression of OCT4 and SOX2 can yield high efficiency on iPSCs
generation (OECiPSCs) when using a protocol with four-reprogramming factors. Compared
with ocular stromal cell-generated iPSCs (OSCiPSCs), OECiPSCs display higher efficiency for
retinal pigmented epithelial cell differentiation.
Materials and Methods
Isolation of conjunctival epithelial cells (OECs) and conjunctival stromal
cells (OSCs)
Collection of conjunctival tissues was approval by Clinical Research Ethical Review Board of
the Medical College of Xiamen University (Permit Number: 20090412–1). For protection of
personal data, ethical review board approved acceptance of patients’ verbal consents to use dis-
carded conjunctival biopsies following eye surgery, documented in the patients’ medical rec-
ords. The discarded samples from three donors were documented with code numbers only and
personal data (i.e., full name/ID) were collected. Epithelial tissues and stromal tissues were sep-
arated aseptically under a stereo microscope (Olympus S2X2-ILLT) in the AireGard Horizon-
tal Laminar AirflowWorkstation (NuAire, Cat. No. NU-201-230E). Tissues (both epithelial
and stromal) were cut to pieces approximately 3x3 mm². Epithelial tissue was cultured in Kera-
tinocyte Serum-Free Medium (KSFM). (Cat. No. 17005–042, Life Technologies). Stromal tissue
was cultured in Stromal Cell Culture Medium (SCCM). A monolayer of conjunctival epithelial
cells (OEC) or conjunctival stromal cells (OSC) emerged from the corresponding tissues within
a week. We kept our passage number<5 in both cultures. Formulation of SCCM was as follow:
Dulbecco’s Modified Eagles Medium (DMEM) (Cat. No. SH30022.01, Thermo Scientific); 10%
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Fetal Bovine Serum (FBS) (Cat. No. 16000–044, Life Technologies); 100 U/ml Penicillin-Strep-
tomycin (P/S) (Cat. No. 15140–122, Life Technologies); 100 U/ml Amphotericin B (Cat. No.
1397-89-3, Sigma). Information about the ocular samples and their corresponding iPSCs is
provided in S1 Fig.
Immunofluorescence staining andWestern Blotting
Standard immunochemistry staining and Western blotting were performed according to previ-
ous descriptions [16]. Briefly, ocular sections were embedded in paraffin wax, de-waxed, anti-
gen unmasked and stained with a DAB kit (Cat. No. ab64238, Abcam) according to the
manufacturer’s instructions. For standard immunofluorescence staining, cells were fixed in 4%
paraformaldehyde for 30 minutes, washed, blocked and permeabilized in blocking solution.
Cells were incubated with primary antibodies in blocking solution at 4°C overnight, washed
twice and incubated with the corresponding secondary antibodies (Cell Signaling Technology)
for 1 hour at room temperature. Cells were washed twice and stained with DAPI (Sigma) for 5
minutes, and then observed and photographed using a LEICA DMI6000B microscope (Leica
Microsystems GmbH). Standard Western blotting was performed as previously described [16].
Membranes were developed using Immobilon Western Chemiluminescent HRP Substrate
(Cat. No. P36599A, Millipore). (Antibodies used in immunochemistry and immunofluores-
cence and Western blotting were listed in S2 Fig).
RNA isolation, reverse transcription, semi-quantitative PCR and real-
time PCR
Total RNAs from iPSCs lines were extracted using a RNAMini Kit (Cat. No. 74104, Qiagen).
Reverse transcription was performed using 0.5 μg RNA in a final volume of 20 μl, using Prime-
script RT reagent kit (Cat. No. HRR047 A, TaKaRa), according to the manufacturer's instruc-
tions. Details of a panel of pluripotent genes and their corresponding primers are summarized
in S3 Fig. Semi-quantitative reverse transcriptase PCR was performed with the designed prim-
ers of the targeted genes (S3 Fig) by Pfu DNA polymerase kit (Cat. No. M7741, Promega) as
per the manufacturer's protocol. The PCR conditions were 95°C for 1min; 30 cycles of 95°C for
30 secs, annealing temperature 42°C for 30 secs, and 72°C for 2 mins; and a final extension at
72°C for 5mins. Beta-actin was used for normalization and all items were measured in tripli-
cates. RT Real-time PCR was performed with the designed primers of the targeted genes (S4
Fig) by RT Master Mix (Cat No. HRR036A, TaKaRa) and CYBR Green Mix (Cat No.
HRR820A, TaKaRa) as listed in manufacturer’s protocols. Real-time PCR was performed with
Real-time PCR system (Step-one Plus, Applied Biosystems, Life Technologies).
Generation of iPSCs from conjunctival stromal cells (OSCs) and
conjunctival epithelial cells (OECs)
OSCs and OECs were maintained in SCCM and KSFM respectively. Two successive rounds of
infection were performed as described [15]. Briefly, cells were infected with viral supernatant
generated by transfection of 293T cells with retroviral PMXs vectors (Addgene) containing the
cDNAs of human KLF4, cMYC OCT4 and SOX2. After the second round of infection, trans-
duced cells were cultured in iPSCs medium. Infection efficiency was separately monitored. As
demonstrated by GFP- transduced expressing cell, the efficiency of our iPSCs generation was
close to 100% (S5 Fig). On day 3, 50,000 cells were seeded onto a layer of feeder and maintained
with iPSCs medium (Life Technology, Cat No: A1412901). On day 7, the culture was main-
tained in iPSCs medium in addition with the addition of valproic acid (VPA; 1mM) (Cat No.
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1069665, Sigma). On Day 10, the medium was changed to iPSCs medium without VPA. On
Day 10–20, colonies that were sufficiently large and resembling human ESCs (i.e. flat morphol-
ogy with defined borders and big nuclei containing prominent nucleoli) were selected mechan-
ically and expanded in human iPSCs medium on feeders as described previously [15].
Alkaline phosphatase staining
Briefly, culture was fixed with 4% paraformaldehyde for 20 mins, washed with PBS and stained
with alkaline phosphatase for 0.5–2 hrs. Excess stain was removed with PBS and the culture
viewed under light microscope.
Characterization of human iPSCs
To characterize the iPSC lines, standard procedures were performed: 1) immunostaining for
pluripotent markers; 2) teratoma formation; 3) H&E staining; 4) karyotyping and 5) bisulfate
conversion-pyrosequencing.
For immunofluorescence staining, the standard procedures were used as described in Meth-
ods and Materials. Primary antibodies used in the staining were listed in S2 Fig. The corre-
sponding secondary antibodies were purchased from Cell Signaling Technologies.
For hematoxylin/eosin (H&E) staining on teratomas, iPSCs were injected subcutaneously or
intramuscularly into the right hind leg of immunocompromised NOD/SCID mice. Teratomas
were excised after 8 weeks, fixed, embedded in paraffin, sectioned and stained with hematoxy-
lin / eosin.
For karyotyping, standard G-banding chromosome analysis was carried out as previously
described [16]. Briefly, the iPSCs were trypsinized and fixed in 3:1 methanol/acetic acid. The
fixing procedure was repeated three times. Finally, the pellet was suspended in a final volume
of 1.5 ml of fixative, and the cells dropped onto glass slides. Metaphases of cells were G-banded
and karyotyped in accordance with the International System for Human Cytogenetic Nomen-
clature recommendations (1995). 30 metaphases were analyzed and 3 were fully karyotyped for
this cell line using a conventional microscope and the Goodline-software (Beijing).
For Bisulfite conversion and pyrosequencing, OECs, OSCs and IMR90 and their corre-
sponding iPSCs were harvested for bisulfite and pyrosequencing as follows. Bisulfite conver-
sion and pyrosequencing were done according to the methods described in 2007 Nature
Protocols[22]. Briefly, in three parts: (Part 1) bisulfite treatment, (Part2) amplifying the regions
of interest in the bisulfite conversed samples by PCR and (Part3) pyrosequencing. (Part1)
Bisulfite treatment. 1mg DNA was bisulfite converted treated with CpGenome Fast DNAMod-
ification Kit (Millipore Cat. No. S7824) according to manufacturer’s instructions. (Part 2) The
region of interest in the bisulfite-converted samples was amplified by PCR using AmpliTaq
Gold 360 Master Mix (Life Technologies, Cat. No. 4398881) according to listed in manufactur-
er’s instructions. Positive and negative controls were included. The PCR was placed in a ther-
mal cycler (Applied Biosystems, Gene Amp PCR systems 9700, 96-Well Gold-Plated; Cat. No.
4314878) activating the polymerase by incubating at 95°C for 15 min. The amplification reac-
tion was carried out for 30 cycles with 30 sec denaturation at 95°C, annealing at approximately
60°C for 30 sec, and extension for 10 sec at 72°C. Only single, strong bands of amplified prod-
ucts were further processed. Biotin-labeled amplification primers were listed in S6 Fig (Part 3)
Pyrosequencing. Samples were sent to Genome Center of The University of Hong Kong, for
Pyrosequencing Service using the Qiagen pyrosequencing system and softwares (Biotage-Qia-
gen PSQ 96MA). The sequence runs were analyzed by the Q-CpG software. CpG islands were
listed in S7 Fig.
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Microarray and data analysis
For each sample, OEC1, OEC2, OSC, OEC1iPSC, OEC2iPSC, OSCiPSC and hESC, we per-
formed a microarray with Affymetrix Human Genome U133 plus 2.0 arrays on two replica-
tions. Total RNA was extracted from cultured cells using the RNeasy Mini Kit (Cat. No. 74104;
Qiagen, Valencia, CA). Five micrograms of total RNA was used for microarray hybridization.
The fragmented complementary RNA was hybridized with the Human Genome U133 plus
chips (Affymetrix, Santa Clara, CA), using the Hybridization Oven 640 (Affymetrix). The
washing and labeling procedures were performed using the Fluidics Station 400 (Affymetrix)
according to the manufacturer's instructions. The arrays were scanned using the GeneChip
Scanner 3000 (Affymetrix), and the signal intensity for each transcript was determined using
Microarray Suite Software 5.0 (Affymetrix). Statistical data analysis was carried out using soft-
ware JMP (SAS, North Carolina).
The top 20 genes preferentially up-regulated in OECs were investigated by the DAVID Bio-
informatics Resources 6.7. Enrichment analysis was based on the DAVID recommended func-
tional annotations, including OMIM disease, sequence feature, Gene Ontology, KEGG
pathway, protein domain, etc. When members of two independent groups could fall into one
of two mutually exclusive categories, the Fisher Exact test was applied to determine whether
the proportions of those falling into each category differed by group. In the DAVID annotation
system, the Fisher Exact was adopted to measure the gene-enrichment in annotation terms.
The background here is all the 23483 genes Affymetrix Human Genome U133 plus 2.0 arrays.
The EASE Score and a modified Fisher Exact P-Value were obtained for each annotation term
involved: the smaller the EASE Score, the more the particular gene was enriched. Each enrich-
ment score of the particular individual gene group stands for the geometric mean of negative
denary logarithm of EASE scores of those terms involved in the particular group.
Differentiation of human iPSCs
To determine the in vitro differentiation potential of OECiPSCs, OSCiPSCs and iMR90iPSCs,
the iPSCs were subjected to sphere culture for 7 days followed by monolayer culture for 3 days.
Cells were harvested for testing endodermal, mesodermal and ectodermal markers. For ocular
surface epithelial differentiation, the iPSCs colonies were grown on collagen IV coated plates
cultured with SHEMmedium for 2 days followed by KSFMmedium for 7–21 days until epithe-
lial-like cells emerged from the differentiating OECiPSCs. SHEM formulation: DMEM/F12
(Cat. No. Hyclone SH30023.01) FBS (Cat. No.16000-044, Life Technologies) 5% HEPES (Cat.
No.151630-080, GIBCO) Insulin-Transferrin-Selenium (ITS; 100x) (1%) (Cat. No. 51500–056,
GIBCO); (100x) Hydrocortisone (0.5 μg/ml) (Cat. No. 0025012ID, Life Technologies); Dimethyl
sulfoxide (DMSO; 0.5%) (Cat. No. 67685, Sigma); EGF (2ng/ml) (Cat. No. PHG0311, Life Tech-
nologies). For retinal pigmented epithelial differentiation, we used an ‘‘retinal determination”
protocol typically resulting in cultures with 80% retinal cells in the presence of insulin growth fac-
tor 1 (IGF1), Dickkopf-1(DKK-1) and Noggin [15–17]. Immunofluorescence staining of the dif-
ferentiated cells from IMR90, OSCs and OECs was performed with the standard protocol as
described previously in our Methods and Materials. The markers used in this step are listed in S2
Fig. The corresponding secondary antibodies were purchased from Cell Signaling Technology.
Statistical analysis
Data were expressed as mean ± standard deviation (SD). The significant differences between
groups were analyzed with unpaired Student t-test for the two groups, or one-way ANOVA fol-
lowed by Bonferroni test for more than 2 groups. All data was analyzed with SPSS10.0 software
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package for Windows (SPSS Inc., Chicago, IL). A value of P<0.05 was considered statistically
significant.
Results
Expression of pluripotency reprogramming factors in conjunctival
epithelial cells from human conjunctival tissue explants
We recently isolated conjunctival epithelial cells (OECs) and conjunctival stromal cells (OSCs)
from individual conjunctival specimen in conditioned cultural medium (S5 Fig). Using a char-
acterized antibody (Santa Cruz Biotechnology, CA. Cat No: SC-8626) that specifically targeted
the pluripotency factor OCT4A [17], we detected OCT4A expression mainly in the basal layer
of conjunctival epithelium, but not in the stromal cell layers (Fig 1A). Immunofluorescence
staining also disclosed that OCT4A is expressed mostly in conjunctival derived OECs, not in
OSCs (Fig 1B). Similarly, pluripotency reprogramming factors, OCT4A and SOX2 are highly
expressed in the basal layer of conjunctival epithelium rather than the stromal cell layers (Fig
1Ci). This is consistent with previous reports that OCT4 and SOX2 are expressed in corneal
and conjunctival epithelium [18–20] In addition, isoform OCT4B was found widely expressed
in OECs, OECiPSCs, OSCs, OSCiPSCs, skin fibroblast IMR90 (ATCC, CCL-186) and
IMR90iPSCs (Fig 1Cii). Retrovirus-mediated reprograming factor OCT4 can be detected in
OECiPSCs and OSCiPSCs, but not in OECs, OSCs and IMR90 somatic cells. (Fig 1Cii; S3 Fig
for primers). Western blotting revealed expression of OCT4A in both human and mouse OECs
at approximately 10%-15% of the protein level found in iPSCs (Fig 1D and 1Ei). Meanwhile,
another reprogramming factor, SOX2, was also detected in mouse and human OECs (Fig 1D
and 1Eii).
Compared with OSCs, RT-PCR confirmed a higher expression of some pluripotency genes
(e.g., REX1, ESG1, OCT4A, SOX2, KLF4 and c-MYC) in OECs (Fig 1Ci). Notably, only OCT4
and SOX2 were expressed in embryonic stem cells (ESCs) and OECs, and were absent in OSCs
(Fig 1Ci,  marked). Furthermore, KLF4 and c-MYC were also present in OECs in addition to
OCT4 and SOX2. Nonetheless only KLF4 and c-MYC were identified in OSCs (Fig 1Ci). The
endogenous expression of reprogramming factors in OECs provides important clues that
OECs may offer a favorable somatic cell source for the generation of iPSCs.
Efficiencies of human iPSCs derived from conjunctival epithelial cells
(OECs) and conjunctival fibroblasts (OSCs)
We examined the susceptibility of these two cell types to retroviral transduction; GFP-encoding
retroviral supernatant was used to infect OECs and OSCs obtained from an individual in a sin-
gle biopsy. No significant differences were observed in the percentage of transduced cells (indi-
cated by the percentages of GFP-positive cells) or their corresponding median intensity of GFP
fluorescence (S5 Fig). Thus retroviral transduction efficiency in this study did not explain dif-
ferences in reprogramming efficiencies among OECs and OSCs.
To test the timing of reprogramming OECs and OSCs by the four factors, the same retrovi-
ral supernatant was used for the transduction of primary OECs and OSCs. One day following
infection, OECs and OSCs culture was changed to culture in ESCs medium and maintained on
mouse stromal feeders for iPSCs generation as previously described[15, 16]. Morphologically,
nascent hESCs-like colonies could be identified in OECs culture as early as 10–12 days post-
infection, (Fig 2A & 2Bii). This was approximately 5–7 days earlier than our OSCs culture and
10 days earlier than skin stromal cells[21].
Pluripotency Reprogramming of Human Conjunctival Cells
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To test the efficiency of reprogramming OECs and OSCs by the four factors, Alkaline Phos-
phatase(AP) staining was performed to count the generated iPSCs colonies from 50,000 loaded
for OECs or OSCs cultures respectively. To do this, the same retroviral supernatant was used to
transduce primary OECs and OSCs. We obtained ~760 OECiPSCs colonies (652 ± 104, N = 3)
from ~50,000 infected OECs (Fig 2C and 2D). The reprogramming efficiency to iPSCs was
quantified based on cell morphological criteria and Alkaline Phosphatase-positive (AP+) stain-
ing. OECs displayed an overall reprogramming efficiency close to 1.5%. For OSCs, infection
was done in parallel. Around 100 granulated colonies and ~50 hESC–like AP+ colonies (46
±15, N = 3; Fig 2C and 2D) were obtained at the 30thday post-infection from ~50,000 infected
OSCs, giving an overall efficiency up to 0.1% (Fig 2D, P<0.01).The efficiency of iPSCs gener-
ation from OECs (1.5%) is higher than that of our OSCs (0.1%) and the karotinocytes (1%)
from the previous report [10], on the same ~50,000 starting primary cells for reprogramming.
In addition, efficiency of OSC reprogramming was at least 10-fold higher than that of skin stro-
mal cell reprogramming that ranged from 0.001%-0.01% [22]. These results show that OECs
are more amendable to pluripotency reprogramming than most other cell types, e.g. OSCs.or
skin stromal cells.
Characterization of pluripotency and comparison of gene expression
profiles of the generated OECiPSCs and OSCiPSCs
Several iPSCs-like colonies generated from OECs and OSCs were selected and expanded, and
cell lines established for pluripotency characterization. Pluripotency markers OCT4, NANOG,
SOX2, SSEA-4 and TRA-1-81 were positively detected by immunofluorescence staining in
both OECiPSCs and OSCiPSCs (Fig 3A and 3B respectively). When these iPSCs lines were sub-
cutaneously injected into immune deficient SCID mice, teratoma formation was observed
around 8–12 weeks post-injection of both OECiPSCs and OSCiPSCs. Sectioning of representa-
tive teratomas revealed that the tissues constituted mesodermal, endodermal and ectodermal
germ-layer cell types, including cartilage, gland and pigmented cells/ or neural cells (Fig 3C) in
both OECiPSCs and OSCiPSCs. Karyotyping analysis of OECiPSCs line revealed normal chro-
mosomal structures (Fig 3D). Another hallmark of successful reprogramming of somatic cells
into pluripotent stem cells is the low methylation of pluripotent genes that are hypermethylated
in differentiated cells. To this end, we analyzed the well-characterized OCT4 promoter region
that was highly methylated in OECs, OSCs or IMR90 but became demethylated in their corre-
sponding iPSCs lines. Our data in methylation study demonstrated successful epigenetic repro-
gramming of somatic cells to pluripotent status (Fig 3E and S3 and S7 Figs). One interesting
finding is that OECs endogenously express higher OCT4 but also higher methylation on its
promoter in OECs as compared to OSCs or IMR90 fibroblast; it suggests expression level of
gene is not always parallel to methylation status. This phenomena had been reported that gene
expression is not always inversely correlated with the methylation regulation on CpGs pro-
moter [23].
Fig 1. Endogenous expression of OCT4A and SOX2 pluripotency reprogramming factors in OECs derived from conjunctival tissues. (A) DAB-
based immunohistochemistry staining displayed the expression of OCT4A (brown, arrows) in human ocular sections. OCT4A expressed in the epithelium
layer but not in stromal layers (OEL, ocular epithelial layer; OSL, ocular stromal layer). (B) Immunofluorescence staining demonstrated OCT4A expression in
OECs but not in OSCs. (C) (i) Reverse transcription polymerase chain reaction (RT-PCR) results in expression of pluripotency genes (from top to bottom
Panels):DPPA4, TERT, NANOG, GDF3, REX1, ESG1,OCT4A, SOX2, KLF4 andC-MYC and Beta- actin. Human ESCs and water were included as positive
and negative controls respectively. (ii) Expression of OCT4 isoforms OCT4A and OCT4B, endogenous OCT 4 and viral OCT4 detecting using 5’ and 3’ UTR
sequences tracking with RT-PCR. (From left to right) Primary lines (IMR90, OEC1, OEC2 and OSCs) and their corresponding iPSCs. (D)Western Blotting for
OCT4A and SOX2 protein levels in OECs, OSCs and iPSCs. Lane 1: OECiPSCs, Lane 2: OSCs, Lane 3&4: OEC1&2 respectively, Lane 5: mouse OECs (E)
Expression levels of (i) OCT4A and (ii) SOX2 were represented in intensity ratios respectively.
doi:10.1371/journal.pone.0131288.g001
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Fig 2. Efficiency of human iPSCs generation fromOECs. (A) Schematic representation on human iPSCs generation from human OECs. (B) Bright view
images on iPSCs generation (i)OECs primary cells (ii)OECiPSCs on feeders (iii)OECiPSCs on feeder free culture. (C) Alkaline phosphatase (AP)-staining
for iPSCs-like colonies derived from (i)OSCs & (ii)OECs. (D)Quantitative analysis of AP-positive iPSC-like colonies between OSCiPSCs and OECiPSCs
OSC-iPSCs vs OEC-iPSCs: (46.33±15.50; 635±127.57) (SD; N = 3, **P<0.01).
doi:10.1371/journal.pone.0131288.g002
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We next compared genome-wide transcriptional profiles of OECs, OSCs, and hESCs with
their respective iPSCs. There are 2925 of 23483 genes found>2 folds in OECs compared with
OSCs, and 7811 out of 23483 genes were observed above>0.5 and<2 folds in OECs. On the
other hand, OEC1iPSCs, OEC2iPSCs and OSCiPSCs shared 3249 genes (with coefficient of
variation less than 300). Among the 3249 genes, 768 genes were preferentially expressed in
OECs (>2 folds, comparing OECs with OSCs), but only 433 genes were preferentially
expressed in OSCs (>2 folds, comparing OSCs with OECs) (Fig 4A). These suggest that, OECs
express more of these common genes of iPSCs than OSCs. This data may provide some molec-
ular explanation of why OECs obtain pluripotency easier than OSCs on ‘KMOS’
reprogramming.
Fig 3. Characterization of pluripotency of OECiPSCs and OSCiPSCs. (A) Immunostaining of
pluripotency markers in OECiPSCs. (i-iii)OCT4, (iv-vi) SOX2, (vii-ix) NAGONG and (x-xii) SSEA-4. (B).
Immunostaining of pluripotency markers in OSCiPSCs. (i-iii)OCT4, (iv-vi) TRA-1-81, (vii-ix)NANOG and (x-
xii) SSEA-4 (C) Hematoxylin and eosin staining of teratoma tissues harvested from SCID mice after
OECiPSCs and OSCiPSCs injection. Teratomas from both OECiPSCs and OSCiPSCs were constituted with
mesodermal, endodermal and ectodermal germ-layer cell types, including cartilage, gland and pigmented
cells/ or neural cells. (D) Karyotypes of representative iPSCs, OECiPSCs, was analyzed and normal
chromosome structures were observed (OSCiPSCs chromosome structures similar to OECiPSC, data not
shown).(E) Bisulfite conversion pyrosequencing data showing the percentages of methylation onOCT4
promoter of the primary cells (IMR90, OSCs and OECs) verus their corresponding iPSCs (IMR90iPSCs,
OSCiPSCs and OECiPSCs).
doi:10.1371/journal.pone.0131288.g003
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Pairwise comparisons of OSCs vs OSCiPSCs, and OEC (1&2) vs OEC (1&2)-iPSCs con-
firmed the distinction of somatic cells and iPSCs with low correlation coefficients of 0.868 and
0.846 & 0.831 respectively (Fig 4B). In contrast, the correlation coefficients of OSCiPSCs,
OEC1iPSCs, and OEC2iPSCs with the same reference ESCs (H9) were virtually identical at
0.988, 0.964, and 0.960, respectively (Fig 4B). This suggests that OSCiPSCs and OECiPSCs are
very similar to ESCs. Pairwise comparison of global gene expression by OEC1 and OSCs
revealed a correlation coefficient of 0.867 (Fig 4B). This result suggests that despite shared
expression of common genes, there are also significant differences between OECs and OSCs.
The top 20 genes preferentially up-regulated in OECs were classified into biological pro-
cesses using the NIH DAVID Pathway Analysis [22, 24]). It revealed that OECs are tightly
involved in the regulation of EGF signaling to maintain epithelial function, cell proliferation
and apoptosis. All of these functions are crucial to cell reprogramming (Fig 4C and S8 Fig).
Retinal pigmented epithelial differentiation and gene expression profiles
of iPSCs lines generated from various cell origins
To compare the pluripotency of different types of iPSCs, OECiPSCs and OSCiPSCs were sub-
jected to sphere culture for 7 days, then monolayer culture for further 3 days. Cells were har-
vested for testing endodermal, mesodermal and ectodermal markers by real-time PCR. The
expression level of pluripotency markers Pou5f1 (OCT4), Sox2 and Dnmt3a were dramatically
decreased up to 1000 times in both differentiating OECiPSCs and OSCiPSCs. The OSCiPSCs
appeared to have a preference for endodermal differentiation and OECiPSCs showed higher
potential in ectodermal differentiation (Fig 5A). After 3 weeks of retinal differentiation proto-
col, the confined pigmented cells (black cells) were merged from differentiating OECiPSC clus-
ters. After manually separating pigmented cell colonies into high-density cultures, the cells
were able to re-acquire the morphology and pigmentation of RPE-like cells. These pigmented
cells were putative RPE-like cells, confirmed by their immunoactivity for mature RPE marker,
RPE 65 (DAPI/blue) (Fig 5B). The highest gene expression level of RPE cell markers, RPE65
and MITF, was observed in OECiPSCs, compared to the differentiating OSCiPSCs and
IMR90iPSCs under same RPE differentiation conditions (Fig 5C).
Immunostaining for the epithelial differentiating iPSCs, under conditions of SHEM
medium following with KSFMmedium for 14 days (Fig 6A), revealed that K3, K19 and
P63-positive cells in OECiPSCs and OSCiPSCs (Fig 6B). Quantitatively analysis of 1000 cells
K3, K19 and P63-positive cells showed that, compared to differentiated OSCiPSCs, differenti-
ated OECiPSCs have more K3, K19 and P63-positive at 68.6± 5.9% v.s 29.7± 4.4%, 48.0± 2.2%
v.s 10.2± 1.0%, and; 12.6± 1.1% v.s 4.5± 0.6% respectively (Fig 6C). In addition, we performed
immunostaining against K19, P63 and RPE65 in OECiPSC-induced teratoma sections. Abun-
dant K19-positive cells, P63-positive cells and RPE65-positive cells (retinal pigmented epithe-
lial marker) were detected, and generally dispersed throughout the tumor tissue sections (S9
Fig). Beneficial upregulation of PAX6 expression was observed in OECiPSCs for ocular cell
lineage differentiation. Gene expression profiles on selected ocular genes were tested among
OECiPSCs, OSCiPSCs, ESCs and IMR90iPSCs (S10 Fig and Fig 7).
Fig 4. Pairwise comparison of global gene expression among different cells. (A) 3249 different genes were preferentially expressed among the iPSCs
lines (IMR90iPSCs, OSCiPSCs and OECiPSCs). Among those 3249 genes, there were 768 genes preferentially presented in OECs when compared to
OSCs above 2-fold cutting-off difference. There were only 433 genes preferentially presented in OSCs when compared with OECs above 2-fold cutting-off
difference. (B) Correlation coefficients between different cell types in genome-wide transcriptional profiles were listed among hESC, OSC, OSCiPSCs,
OEC1, OEC1iPSCs, OEC2, OEC2iPSCs. (C) The top 20 genes preferentially up-regulated in OEC1 vs. OSC were classified into biological processes using
the NIH DAVID Pathway Analysis. Data for OEC2 vs OSC is presented in S8 Fig.
doi:10.1371/journal.pone.0131288.g004
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Analysis from microarray data revealed 8.04 and 77.61-fold increased expression of PAX6
in OECiPSCs when compared to OSCiPSCs and ESCs respectively (S10 Fig). When compared
with OSCiPSCs, OECiPSCs showed 4.82, 2.29 and 2.27 fold regulation of RPE65, COL3A1 and
SOX2 expression respectively (S10 Fig). When compared with ESCs, OECiPSCs showed 8.58
and 4.18folds upregulation of COL3A1 and SOX2 expression (S10 Fig). To validate the above
microarray data, we performed RT real-time PCR on selected ocular genes (Fig 7). We con-
firmed upregulation of PAX6, RPE65 and K19 genes in OECiPSCs compared with ESCs,
OSCiPSCs and IMR90iPSCs. For instance, PAX6 level of OECiPSCs was upregulated by 140.34
Fig 5. Ocular epithelial differentiation from different cell-of-origin iPSCs lines. (A) To compare the pluripotency nature of different types of iPSCs,
OECiPSCs and OSCiPSCs were subjected to sphere culture for 7 days then monolayer culture for further 3 days. Cells were harvested for testing
endodermal, mesodermal and ectodermal markers by real-time PCR. Expression level of pluripotency markers Pou5f1, Sox2 and Dnmt3a were dramatically
decreased up to 1000 times in both differences in OECiPSCs and OSCiPSCs. The OSCiPSCs demonstrated a preference for endodermal differentiation
while OECiPSCs show higher potential in ectodermal differ nation. iPSCs vs OECiPSCs vs OSCiPSCs: Pou5f1 (0.00±0;-3.56±0.06;-2.98±0.07); Sox2 (0.00
±0;-2.83±0.04;-3.25±0.03); Dnmt3a (0.00±0;-2.42±0.03;-3.01±0.04); Sox17 (0.00±0; 1.08±0.04; 1.48±0.03); Foxa2 (0.00±0; 1.35±0.04; 2.12±0.03); AFP
(0.00±0; 1.23±0.23; 1.41±0.47); T (0.00±0; 2.21±0.04; 1.41±0.03); Kit (0.00±0; 2.17±0.0; 2.62±0.03); Nestin (0.00±0; 2.65±0.20; 1.56±0.22); Pax6 (0.00±0;
2.75±0.04; 2.23±0.11); (SEM N = 3;*P<0.01vs OSCiPSCs-EB; #P<0.01vs OECiPSCs-EB). (B) (A) After 3 weeks of retinal differentiation protocol, the
confined pigmented cells (black cells) were merged from differentiating OECiPSC clusters. (B-D) After manually picked up pigmented cell colonies into high-
density cultures, the cells were able to re-acquire the morphology and pigmentation of RPE-like cells. (E-H) These pigmented cells were putative RPE-like
cells as confirmed by immunoactivity for mature RPEmarker, RPE 65 (DAPI/blue). (C) After 3 weeks, the increased expression level of RPE cell markers,
RPE65 and MITF, were significantly different among OECiPSCs, OSCiPSCs and iMR90iPSCs under same RPE differentiation conditions. iPSCs vs
OECiPSCs vs OSCiPSCs vs iMR90iPSCs: RPE65(0.00±0;2.62±0.04;1.66±0.37;1.02±0.09); MITF (0.00±0; 1.83±0.06; 1.1±0.19; 1.03±0.07). (Log SD; N = 3,
*P<0.01 vs iPSCs; #P<0.01 vs OSCiPSCs-RPE;ƗP<0.01 vs iMR90iPSCs-RPE)
doi:10.1371/journal.pone.0131288.g005
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folds that of ESCs, PAX6 level of OECiPSCs is upregulated by 11.97 and 131.56 fold than that
of OSCiPSCs and IMR90iPSCs respectively (Fig 7i). For RPE65 expression level, OECiPSCs
showed an upregulation of 1.59 and 1.20 fold when comparing to OSCiPSCs and IMR90iPSCs
respectively (Fig 7iii). Furthermore, OECiPSCs showed upregulation in K19 expression with
2.85, 2.12 and 8.38 fold increase compared to ESCs, IMR90iPSCs and OSCiPSCs respectively
(Fig 7ii). Combined microarray and RT real-time PCR analysis revealed a high basal level of
PAX6 and other ocular –related genes (RPE65, COL3A1 and K19) in OECiPSCs compared
with other iPSCs, suggesting OECiPSCs are a promising iPSCs source for ocular epithelial
differentiation.
Discussion
In our study, ocular epithelial cells (OECs), with expression of endogenous reprogramming
factors OCT4 and SOX2, provide a very attractive somatic cell source for highly efficient iPSCs
Fig 6. Efficiency of ocular epithelial differentiation in OSCiPSCs and OECiPSCs. (A) Epithelial differentiation of OECiPSCs under conditions of SHEM
medium following by KSFMmedium for 14 days. (B) Immunostaining revealed that K3, K19 and P63-positive cells were observed in OECiPSCs and
OSCiPSCs. (C)Quantitatively analysis for K3, K19 and P63-positive cells showed that, compared to differentiated OSCiPSCs, differentiated OECiPSCs
have more K3, K19 and P63-positive cells. OECiPSCs vs OSCiPSCs: K3 (68.6±5.9%.; 29.7±4.4%); K19 (48.0%±2.2%; 20.2%±1.0%); P63 (12.6%±1.1%;
2.5%±0.6%). (SD; N = 3;*P<0.01).
doi:10.1371/journal.pone.0131288.g006
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generation. In addition, OECiPSCs displayed stronger potentials for ocular epithelial differenti-
ation (i.e. RPE cells) than OSCiPSCs, which may be associated with high basal level of PAX6,
an essential element for ocular development. Cell origin is found to influence iPSCs generation
although the underlying mechanisms are not fully understood. It has been suggested that
somatic cells in an advanced state of reprogramming tend to have superior reprogramming
efficiencies, and the corresponding reprogramming status is reflected by the endogenous
expression of pluripotent factors [25]. For example, compared with terminal differentiated
somatic cells (e.g., T lymphocytes) and progenitor cells (e.g., neonatal cord blood stem cells
and neural progenitor cells) are more easily reprogrammed to pluripotency. Only the introduc-
tion of OCT4 or/and SOX2 is sufficient to induce pluripotency in these cell sources [11]. In
contrast, four factors are required for reprogramming terminal T cells to pluripotency [26].
Nonetheless, the availabilities of neonatal cord blood stem cells and neural stem cells are lim-
ited in adults. Among adult somatic cells, previous reports demonstrated that epithelial cells
were more easily induced towards pluripotency than stromal cells. For example, it has been
documented that a mesenchymal-to-epithelial transition (MET) is required to induce stromal
cells towards pluripotency, and that prevention of epithelial-to mesenchymal transition (EMT)
can produce iPSCs without introducing KLF4 and c-MYC in epithelial cells culture[27].
Recently, it has been reported that mouse conjunctiva can be reprogrammed into iPSCs and
may provide an alternative source of stem cells[28]. Our data indicates that human ocular epi-
thelial cells (OECs) can be induced to pluripotency with a higher efficiency than conjunctival
stromal cells (OSCs). Indeed, SOX2 is expressed in many epithelial cell types including con-
junctival epithelial cells. More importantly, we found that in conjunctival ocular surface epithe-
lial cells (OECs), but not ocular stromal cells (OSCs), the crucial pluripotent stem cell marker,
OCT4A was expressed. The presence of these pluripotency markers in OECs may be associated
with an advanced status for cell reprogramming. Previous reports indicated that OCT4 alone is
sufficient to reprogram adult mouse and human neural stem cells to iPSCs because endogenous
SOX2 is expressed by neural stem cells [29, 30]. Nonetheless, we could not omit OCT4 to
induce OECs to pluripotency with classic Yamanaka’s 4 factors. In fact, the OCT 4 protein
level was much lower in OECs than in OECiPSCs. Whether introduction of OCT4 factor alone
can induce OECs to iPSCs status requires further investigations on this traditional KMOS
method. It has also been revealed that reprogramming mouse fibroblast cells into pluripotent
cells can be achieved by small-molecule compounds [31]. A more recent study demonstrated
that mouse somatic cells could be reprogrammed by depleting Mbd3 together with KMOS
transduction on a efficiency of ~100% [32].
Treatment with such compounds or Mbd3 suppression on human fibroblast cells has not
been employed in human iPSCs generation. Since activation of OCT4 to appropriately high
level is required for chemical-induced pluripotency reprogramming, it would be of great inter-
est to test such compounds on human OECs instead of fibroblast cells for chemically induced
pluripotency reprogramming.
During stem cells/progenitor cells differentiation, PAX6 is responsible for ocular develop-
ment and normal limbal stem cell activity. PAX6 knockout mice have no lenses[33]. In our
Fig 7. Ocular gene expression profiles among iPSCs. (i&ii) PAX6 and K19 profiles of OECiPSCs compared to ESCs, IMR90iPSCs and OSCiPSCs
respectively. (iii) RPE65 profile of OECiPSCs compared to IMR90iPSCs and OSCiPSCs. (i) Data shows an upregulation of PAX6 (140.34 folds;*** p<0.01)
compared with ESCs; and upregulations of PAX6 (11.97 and 131.56 folds, ***p<0.01) compared to OSCiPSCs and IMR90iPSCs respectively. ESCs (H9)
vs iMR90iPSCs vs OECiPSCs vs OSCiPSCs: PAX6 (1.00±0.00; 1.067±0.12; 140.34±13.86;11.72±1.23) (SD; N = 3; ** P<0.005) (ii) Data shows an
upregulation of K19 (2.85, 2.12 and 8.38 folds, ***p<0.01) compared to ESCs, IMR90iPSCs and OSCiPSCs respectively. ESCs (H9) vs iMR90iPSCs vs
OECiPSCs vs OSCiPSCs: K19 (1.00±0.00; 1.34±0.23; 2.85±0.4137;0.34±0.1138) (SD; N = 3; ** P<0.005) (iii) The profile shows an upregulation of RPE65
(1.59 and 1.20 folds) compared to OSCiPSCs and IMR90iPSCs respectively. IMR90iPSCs vs OECiPSCs vs OSCiPSCs: RPE65 (1.33±0.43; 1.59±0.49;
1.00±0.00 (SD; N = 3; P>0.05).
doi:10.1371/journal.pone.0131288.g007
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microarray and RT real-time PCR data, compared with stromal cell-derived iPSCs
(IMR90iPSCs and OSCiPSCs), the PAX6 expression level in OECiPSCs was higher which may
be associated with great potentials of OECiPSCs to differentiate into ocular epithelial lineage.
Nonetheless, it is possible that these OECiPSCs or OSCiPSCs are induced at pluripotent state
but not reporgrammed to the ground state of pluripotency, even these OECiPSCs formed tera-
toma containing cell types from three germ layers.
Taken together, our findings demonstrate that conjunctival epithelial cells (OECs) can be
more easily converted to iPSCs than stromal cells. This cell type may also have advantages in
retinal pigmented epithelial differentiation.
Supporting Information
S1 Fig. General information of ocular samples and iPSCs generation. Ocular samples 1–3
were collected and each conjunctiva tissue was digested with Dispase II overnight, and sepa-
rated under stereo microscope into two layers, the OECs layer and OSCs layer. The separated
layers were cultured in different conditioned medium for OSCs and OECs outgrowth. The
established OEC1, OSC1, OEC2, OSC2, OEC3 and OSC3 lines were characterized by RT-PCR
and immunofluorescence for their respective ocular identity. They were subjected to pluripo-
tency reprogramming for iPSCs and their respective reprogramming efficiencies were calcu-
lated by AP-staining. The corresponding iPSCs were characterized and differentiated to ocular
epithelial cell type under standard protocols provided in materials and methods.
(PDF)
S2 Fig. A summary of antibodies used in the study. (1) Antibodies for the characterization of
iPSCs with OCT4A, SOX2, NANOG, SSEA4 and TRA-1-81, (2) Antibodies for the characteri-
zation of iPSCs in ocular differentiation with K19, K3, P63 and RPE65. (3) Antibodies for iden-
tifying OCT4A and SOX2 expression in Western blotting analysis.
(PDF)
S3 Fig. Primer sequences of pluripotency genes for RT-PCR in this study. To test the expres-
sion of pluripotency genes in ESCs, OECs and OSCs, forward and reverse primers of the target
genes were designed.
(PDF)
S4 Fig. Primers sequences of selected ocular genes for microarray real time RCR validation.
Primers sequences for K19, PAX6, RPE65 and GAPDH are listed.
(PDF)
S5 Fig. Efficiency of retroviral supernatant infection in OSCs and OECs primary cultures.
Cells were infected with same viral supernatant harvested from PMX-GFP (retroviral) vector-
transfected 293 cell cultures. The cells were subjected to two rounds of infection within
48-hours. Both of OSCs and OECs were highly infected with retroviral particles (GFP-positive)
at similar percentages and fluorescent intensities (i-ii) OECs and (iii-iv) OSCs.
(PDF)
S6 Fig. Methylation Analysis of OCT4 Promoter. The biotin labeled amplification primers
and the pyrosequencing primers of human OCT 4 promoter.
(PDF)
S7 Fig. Bisulfite converted amplicons of human OCT4 promoter. Unmethylated Cytosines
(C) were converted to Uracil (U) and then to Thymine (T) which were typed in red. Cytosines
(methylated) on predicted CpG Islands were replaced with ‘Y’ highlighted with purple. The
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sequences of the pyrosequencing primers are underlined. Sequences highlighted in yellow were
pyrosequencing covered regions.
(PDF)
S8 Fig. Microarray data on the top 20 up-regulated genes in OEC2 compared with OSC.
The genes were ranked in descending order by their corresponding mean fold changes (nor-
malized microarray signal) for OEC2 vs OSC. NIH DAVID Pathway Analysis was used to clas-
sify the biological functions for each gene up-regulated in OEC2.
(PDF)
S9 Fig. Immunostaining against K19, P63 and RPE65 markers in OECiPSCs-induced tera-
toma sections. (i) Abundant K19-positive cells; (ii) P63-positive cells (corneal progenitor
marker) and (iii) RPE65-positive cells (Retinal pigmented epithelial marker) were detected. (i)
Many K19-positive cells were preferentially distributed at inner layer of lumen tissues; (ii) P63-
positive cells were generally distributed in the tissue, (iii) RPE65-positive cells were enriched
regionally forming clustered areas within the tissue.
(PDF)
S10 Fig. Microarray analysis of some important ocular genes up-regulated in OECiPSCs
when compared with ESCs and OSCiPSCs. (1) Gene expression for COL3A1, PAX6 and
SOX2 of OECiPSCs compared with ESCs; (2) Gene expression of COL3A1, PAX6, RPE65 and
SOX2 of OECiPSCs are compared with OSCiPSCs.
(PDF)
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